ابحث بين معلمي الإنجليزية المتعددين...
Brazil flagRenata
What happened today Hi! I am writing today about what happened in a meeting. It's all about Pharmaceutical Industry. Do you guys understand it? I would really appreciate it if you could leave some comments. Thank you! Overview: FAM took a big step with the opening of BioL Company in 2016, for the production and development of industrial-scale Through Productive Development Partnerships (PDP), signed with the federal government, it will be possible to transfer the manufacturing technology of these drugs to the Lavol Institute, which will later also produce them. Currently, all development of biological medicines at FAM is done through an international partnership with Latin America exclusive contract. Recently the Ministry of Health has suspended 19 drug production contracts, the so-called Productive Development Partnerships (PDPs). Among them there was the medicine X. Jack reported that there is a government review with a new ministry and probable will be reversed and it is possible scheduled to be released by the end of September. Discussion: Jack explains about current biologic pipeline ZETA, LUNA (both for arthritis rheumatoid) and X. X is only there is a stability molecule end is possible start the registration process in 1 or 2 years. Jack is interested in launching X on prefill syringe, but this decision must be made by a multi-professional team. Jack mentioned there is expansion project for the injectables line and there is a desire to improve some primary packaging. Next month we will plan a WorkShop for the entire team involved in injectable drugs., focused on information regarding the adaptation, support and interaction of our company with the filling machines.

التصحيحات · 2

0
What happened today

Hi! I am writing today about what happened in a meeting. It's all about the Pharmaceutical Industry. Do you guys understand it? I would really appreciate it if you could leave some comments. Thank you!

Overview:
FAM took a big step with the opening of the BioL Company in 2016, for industrial-scale production and development of industrial-scale. Through Productive Development Partnerships (PDP), signed with the federal government, it will be possible to transfer the manufacturing technology of these drugs to the Lavol Institute, which will later also produce them.
Currently, all development of biological medicines at FAM is done through an international partnership with Latin America exclusive contract. Recently, the Ministry of Health has suspended 19 drug production contracts, the so-called Productive Development Partnerships (PDPs). Among them there was the medicine X. Jack reported that there is a government review with the new ministry and it probably will be reversed and it is possibly scheduled to be released by the end of September.

Discussion:
Jack explains about the current biologic pipeline ZETA, LUNA (both for arthritis rheumatoid) and X.
X is only there is a stability molecule end is possible start the registration process in 1 or 2 years. (I don't understand this sentence)
Jack is interested in launching X on prefill syringe, but this decision must be made by a multi-professional (you may mean multi-disciplinary) team.
Jack mentioned there is an expansion project for the injectables line and there is a desire to improve some primary packaging.
Next month we will plan a WorkShop for the entire team involved in injectable drugs., focused on information regarding the adaptation, support and interaction of our company with the filling machines.
0
Up

هل تريد التطور بشكل أسرع؟

انضم لمجتمع التعلّم هذا وجرّب التمرينات المجانية!

لا تفوّت فرصة تعلّم لغة جديدة وأنت مرتاح في منزلك. تصفّح مجموعتنا المختارة من مدرّسي اللغات ذوي الخبرة وسجّل في درسك الأول الآن!

ابدأ التعلم اليوم